查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1982809

2026-2034年全球药品安全监测和药品安全软体市场规模、份额、趋势和成长分析报告

Global Pharmacovigilance and Drug Safety Software Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 136 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计药物警戒和药物安全软体市场将从 2025 年的 2.5614 亿美元成长到 2034 年的 4.8332 亿美元，2026 年至 2034 年的复合年增长率为 7.31%。

随着製药公司日益重视药物安全监测和法规遵循，全球药物警戒和药物安全软体市场正显着成长。药物警戒软体有助于确保在药物的整个生命週期内进行不利事件追踪、安全资料管理以及符合监管准则。

推动市场扩张的因素有很多。药物研发活动的增加和监管要求的日益严格催生了对先进安全监测系统的需求。此外，临床试验和上市后调查计画的复杂性不断提高，也促使製药公司采用自动化解决方案进行药物安全管理。

随着製药公司持续将患者安全和合规性放在首位，药物警戒和药物安全软体市场预计将会成长。数据分析和人工智慧的进步有望提升检测安全讯号和管理大规模数据集的能力。此外，全球医药市场的扩张预计也将支撑市场需求的持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球药品安全监测与药品安全软体市场：功能

  • 市场分析、洞察与预测
  • 病例资料的收集和管理
  • 不利事件的报告和分析
  • 讯号侦测及其他安全风险评估

第五章 全球药品安全监测与药品安全软体市场：依交付类型划分

  • 市场分析、洞察与预测
  • 现场
  • 一经请求

第六章 全球药品安全监测与药品安全软体市场：依最终用途划分

  • 市场分析、洞察与预测
  • 医疗保健公司（製药和生物技术公司）
  • CRO/BPO 或 PV服务供应商（如果外包）
  • 其他的

第七章 全球药品安全监测与药品安全软体市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • IQVIA
    • Accenture
    • Cognizant
    • Laboratory Corporation Of America Holdings
    • IBM
    • ArisGlobal
    • ICON Plc
    • Capgemini
    • Oracle
    • Parexel International Corporation
简介目录
Product Code: VMR11212598

The Pharmacovigilance and Drug Safety Software Market size is expected to reach USD 483.32 Million in 2034 from USD 256.14 Million (2025) growing at a CAGR of 7.31% during 2026-2034.

The global pharmacovigilance and drug safety software market has grown significantly as pharmaceutical companies focus on monitoring drug safety and regulatory compliance. Pharmacovigilance software helps track adverse drug reactions, manage safety data, and ensure compliance with regulatory guidelines throughout the lifecycle of pharmaceutical products.

Several factors are driving the expansion of this market. Increasing drug development activities and stricter regulatory requirements have created demand for advanced safety monitoring systems. Additionally, the growing complexity of clinical trials and post-marketing surveillance programs has encouraged pharmaceutical companies to adopt automated drug safety software solutions.

Looking ahead, the pharmacovigilance and drug safety software market is expected to grow as pharmaceutical companies continue prioritizing patient safety and regulatory compliance. Advances in data analytics and artificial intelligence may improve the ability to detect safety signals and manage large datasets. Furthermore, the expansion of global pharmaceutical markets will likely support continued demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Functionality

  • Case Data Collection and Management
  • Adverse Event Reporting and Analysis
  • Signal Detection and Other Safety Risk Assessment

By Delivery Mode

  • On Premise
  • On Demand

By End Use

  • Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
  • CROs/BPOs or PV Service Providers When Outsourced
  • Others

COMPANIES PROFILED

  • IQVIA, Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM, ArisGlobal, ICON Plc, Capgemini, Oracle, Parexel International Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY FUNCTIONALITY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Functionality
  • 4.2. Case Data Collection and Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Adverse Event Reporting and Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Signal Detection and Other Safety Risk Assessment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY DELIVERY MODE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Delivery Mode
  • 5.2. On Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. On Demand Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Healthcare Companies (Pharmaceuticals & Biotechnology Companies) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. CROs/BPOs or PV Service Providers When Outsourced Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Functionality
    • 7.2.2 By Delivery Mode
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Functionality
    • 7.3.2 By Delivery Mode
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Functionality
    • 7.4.2 By Delivery Mode
    • 7.4.3 By End Use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Functionality
    • 7.5.2 By Delivery Mode
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Functionality
    • 7.6.2 By Delivery Mode
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 IQVIA
    • 9.2.2 Accenture
    • 9.2.3 Cognizant
    • 9.2.4 Laboratory Corporation Of America Holdings
    • 9.2.5 IBM
    • 9.2.6 ArisGlobal
    • 9.2.7 ICON Plc
    • 9.2.8 Capgemini
    • 9.2.9 Oracle
    • 9.2.10 Parexel International Corporation